Relafen 750, labeled as naproxol, embodies a unique example of targeted biochemical intervention within the realm of inflammatory conditions. From a therapeutic perspective, its mechanism of functioning copyrights upon the reduction of cyclooxygenase (COX) catalysts , particularly COX-2, contributing to the generation of inflammatory mediators . Th